Souheil El-Chemaly, MD, MPH | American Lung Association

Souheil El-Chemaly, MD, MPH

Research Awards Nationwide Recipient (2014-2016)

Brigham and Women's Hospital, Boston, MA
Identifying the Mechanisms Underlying Hermansky-Pudlak Syndrome

Hermansky-Pudlak syndrome (HPS) is a rare inherited disease which causes scarring of the lungs with limited treatment options. We will explore how HPS fibroblasts differ from those in normal lungs and whether treatment can make them behave like normal fibroblasts. These studies will be performed in zebrafish embryos, a new model for studying HPS pulmonary fibrosis which may have use in identifying new treatment targets. Understanding the underlying mechanisms of HPS may accelerate the discovery of therapies for more common lung diseases like cystic fibrosis and idiopathic pulmonary fibrosis.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.